BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 4242393)

  • 1. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):241-3. PubMed ID: 4242393
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H; Huerlimann A; Haefely W
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract]   [Full Text] [Related]  

  • 3. On the mechanism of the adrenergic nerve blocking action of bretylium.
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(3):260-77. PubMed ID: 4243221
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the mechanism of action of new drugs effective upon the autonomic and central nervous system].
    Oberdorf A; Hoffmeister F; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):48-9. PubMed ID: 4231861
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of drugs on adrenergic nerve terminals.
    von Euler US
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of bretylium and acetylcholine at sympathetic nerve endings.
    Fischer JE; Weise VK; Kopin IJ
    J Pharmacol Exp Ther; 1966 Sep; 153(3):523-9. PubMed ID: 5921529
    [No Abstract]   [Full Text] [Related]  

  • 7. On the mechanism of neuromuscular blocking action of bretylium and guanethidine.
    Chang CC; Chen TF; Cheng HC
    J Pharmacol Exp Ther; 1967 Oct; 158(1):89-98. PubMed ID: 4293315
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of sympathetic nerve stimulation frequency-response relationship in rabbit ileum by guanethidine, bretylium and tetracaine.
    Kihara M; Kubo T; Misu Y
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):180-5. PubMed ID: 6667066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopamine-mice and rats-immunosympathectomy-chemical sympathectomy-superior cervical ganglion).
    Angeletti PU; Levi-Montalcini R
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):86-8. PubMed ID: 4333047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pre- and postjunctional effects of 6-hydroxydopamine.
    Haeusler G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):49-62. PubMed ID: 5087404
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
    Tomlinson DR; Mayor D
    Eur J Pharmacol; 1973 Feb; 21(2):161-70. PubMed ID: 4696099
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the mechanism of action of a new antihypertensive substance with imidazoline structure].
    Kobinger W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(1):48-58. PubMed ID: 4233006
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1962 Aug; 19(1):13-41. PubMed ID: 13871863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of acetyl choline and other drugs upon the terminal parts of the postganglionic sympathetic fibre.
    Cabrera R; Torrance RW; Viveros H
    Br J Pharmacol Chemother; 1966 May; 27(1):51-63. PubMed ID: 5961470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adrenergic mechanisms as basis of pharmacological agent action. I].
    Fermum R
    Z Arztl Fortbild (Jena); 1968 Jan; 62(2):109-15. PubMed ID: 4302478
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ultrastructural modifications induced by several drugs on adrenergic nerve endings and on the adrenal medulla].
    Clementi F
    Experientia; 1965 Mar; 21(3):171-6. PubMed ID: 5890429
    [No Abstract]   [Full Text] [Related]  

  • 17. Some factors affecting the neuron blocking action of guanethidine, xylocholine, bretylium and debrisoquin.
    Prasad CM; Shah DS; Gulati OD
    Jpn J Pharmacol; 1973 Dec; 23(6):805-11. PubMed ID: 4544694
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of antiadrenergic compounds on phosphorylase activity in the rat liver during exposure to extremely strong stimulation].
    Korkhov VV
    Farmakol Toksikol; 1969; 32(4):393-6. PubMed ID: 4391078
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antidromic activity induced by acetylcholine in the cardiac sympathetic nerve, and noradrenaline liberation under the influence of guanethidine].
    Häusler G; Thoenen H; Haefely W; Hürlimann A
    Helv Physiol Pharmacol Acta; 1968; 26(3):CR352-4. PubMed ID: 5719362
    [No Abstract]   [Full Text] [Related]  

  • 20. The rôle of sympathetic innervation in pineal-pituitary feed back. Blocking of pineal changes induced in the rat by experimental hypergonadotropinaemia by chronic treatment with bretylium or guanethidine.
    Trentini GP; De Gaetani CF; Palmieri FB
    Ann Endocrinol (Paris); 1973; 34(3):261-70. PubMed ID: 4751203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.